Perimeter Medical Q2 Revenue Doubles to $500K, Driven by Procedure and Recurring Revenue Growth
ByAinvest
Monday, Aug 11, 2025 4:33 pm ET1min read
PMTR--
The company expects its gross margin for Q2 2025 to be 69%, aligning with previous guidance. Additionally, Perimeter Medical Imaging AI projects H1 2025 revenue of $1.0 million, surpassing full-year 2024 revenue of $846,000 [2].
To support its growth, Perimeter Medical Imaging AI has announced a significant 30% reduction in operating costs starting Q3 2025. Key leadership appointments include Abbey Goodman as VP of Sales and Paolo DiPasquale as VP of Corporate Development. Additionally, the company has established an Industry Advisory Board (IAB) to be chaired by Diana Chan, with COO Tom Boon continuing to serve on the IAB [2].
References:
[1] https://seekingalpha.com/news/4483469-perimeter-medical-reports-preliminary-q2-revenue-of-500k-up-100-yoy
[2] https://www.stocktitan.net/news/PYNKF/perimeter-announces-preliminary-unaudited-revenues-for-the-2025-bnayh777unla.html
PRM--
Perimeter Medical Imaging AI reports preliminary Q2 2025 revenue of $500,000, a 100% YoY increase. Revenue growth is driven by a 35% increase in procedures and a 50% increase in recurring revenue compared to Q1 2025. The company's gross margin is expected to be in line with previous guidance.
Perimeter Medical Imaging AI (TSXV:PINK, OTCQX:PYNKF) has reported preliminary Q2 2025 revenue of approximately $500,000, representing a 100% year-over-year (YoY) increase. The company's revenue growth is primarily driven by a 35% increase in procedures and a 50% increase in recurring revenue compared to Q1 2025 [1].The company expects its gross margin for Q2 2025 to be 69%, aligning with previous guidance. Additionally, Perimeter Medical Imaging AI projects H1 2025 revenue of $1.0 million, surpassing full-year 2024 revenue of $846,000 [2].
To support its growth, Perimeter Medical Imaging AI has announced a significant 30% reduction in operating costs starting Q3 2025. Key leadership appointments include Abbey Goodman as VP of Sales and Paolo DiPasquale as VP of Corporate Development. Additionally, the company has established an Industry Advisory Board (IAB) to be chaired by Diana Chan, with COO Tom Boon continuing to serve on the IAB [2].
References:
[1] https://seekingalpha.com/news/4483469-perimeter-medical-reports-preliminary-q2-revenue-of-500k-up-100-yoy
[2] https://www.stocktitan.net/news/PYNKF/perimeter-announces-preliminary-unaudited-revenues-for-the-2025-bnayh777unla.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet